Tamsulosine Pellets

Tamsulosine PelletsTamsulosin is an α1a-selective alpha blocker used in the symptomatic treatment of benign prostatic hyperplasia (BPH).

Tamsulosin was developed by Yamanouchi Pharmaceuticals (now part of Astellas Pharma) and is marketed by various companies under licence, including Boehringer-Ingelheim and CSL.

Tamsulosin hydrochloride extended-release capsules are marketed under the trade names Flomax, Flomaxtra, Contiflo XL, and Urimax, though generic non-modified release capsules are still approved and marketed in many countries, such as Canada.

The U.S. patent for Flomax expired in October 2009.[citation needed] The U.S. Food and Drug Administration (FDA) approved generic Flomax in March 2010.

Dose:
Tamsulosin HCL .4
Tamsulosin HCL 0.4
Tamsulosin HCL 0.4 mg
Tamsulosin HCL 0.4 mg Capsule

Available Form:
Tamsulosine HCL SR Pellets
Tamsulosine Granules

Umang Pharmatech equipments used for production of Tamsulosine Pellets:
Drug Layering, Fluid Bed Dryer, Fluid Bed Coater, Sifter & Blender, Extruder and Twin spheronizer.

Tamsulosine Pellets
Systematic (IUPAC) Name
Tamsulosine Pellets
Identifiers
Tamsulosine Pellets
Chemical data
(R)-5-(2-(2-(2-ethoxyphenoxy)ethylamino)propyl)-2-methoxybenzenesulfonamide
CAS number : 106133-20-4
ATC code : G04CA02
PubChem : CID 129211
IUPHAR ligand : 488
DrugBank : APRD00036
ChemSpider : 114457
UNII : G3P28OML5I
KEGG : D08560
ChEMBL : CHEMBL836
Formula : C20H28N2O5S
Mol. mass : 408.51


* All transactions are carried out in conformity with patent laws applicable in the user country. Active pharmaceutical ingredients or formulations thereof will not be supplied in countries where the same is under patent protection except as and if permitted under law of the country for research and development purposes only.
Extruder Spheronizer Email Us Umang Pharmatech
TESTIMONIAL